Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jeng

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood|February 22, 2018
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, et al.
Science (New York, N.Y.)|February 29, 2024
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaquesSo-Yon Lim, Jina Lee, Christa E Osuna, et al.
The Lancet. Oncology|April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Aging Cell|March 27, 2023
Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in miceNiraj Shrestha, Pallavi Chaturvedi, Xiaoyun Zhu, et al.
Cancer Immunology Research|July 10, 2021
A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer ImmunotherapyMichelle K Becker-Hapak, Niraj Shrestha, Ethan McClain, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood|February 22, 2018
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, et al.
Science (New York, N.Y.)|February 29, 2024
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaquesSo-Yon Lim, Jina Lee, Christa E Osuna, et al.
The Lancet. Oncology|April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Aging Cell|March 27, 2023
Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in miceNiraj Shrestha, Pallavi Chaturvedi, Xiaoyun Zhu, et al.
Cancer Immunology Research|July 10, 2021
A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer ImmunotherapyMichelle K Becker-Hapak, Niraj Shrestha, Ethan McClain, et al.
Pageof 4